Lisa Dalton is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 9,100 shares of NBRV, which is worth approximately $3,640. The most recent transaction as insider was on Jul 31, 2022, when has been sold 8,400 shares (Ordinary Shares) at a price of $0.18 per share, resulting in proceeds of $1,512. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.1K
0% 3M change
0% 12M change
Total Value Held $3,640

Lisa Dalton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2022
SELL
Payment of exercise price or tax liability
$1,512 $0.18 p/Share
8,400 Reduced 48.0%
9,100 Ordinary Shares
Jul 28 2021
BUY
Grant, award, or other acquisition
-
17,500 Added 50.0%
17,500 Ordinary Shares
LD

Lisa Dalton

Director
Fort Washington, PA

Track Institutional and Insider Activities on NBRV

Follow Nabriva Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV